| PESUB20 | Ibalizumab long-term efficacy is not impacted by partially active antiretrovirals | Poster exhibition | ART in highly treatment-experienced persons |
| PESUB19 | Rapid ART initiation: a four-years observational study | Poster exhibition | ART in acute, first- and second-line therapies |
| PESUB18 | PROGRESSION OF HEPATIC STEATOSIS IN PEOPLE WITH HIV ON INTEGRASE INHIBITORS | Poster exhibition | Hepatic complications (e.g., NASH) |
| PESUB17 | DTG associated weight gain: real or perceived? Real world experiences from Zimbabwe | Poster exhibition | Weight gain |
| PESUB16 | The burden of and risk factors for maternal mental health and the impact on parenting by mothers living with HIV in rural Zimbabwe | Poster exhibition | Mental health (including depression and psychiatric manifestations) and HIV |
| PESUB15 | Incidence of and risk factors for heart failure subtypes in women and men living with HIV | Poster exhibition | Cardiovascular disease |
| PESUB14 | Low frequency of activated T cells in people living with HIV, aviremic under treatment, and presenting neurocognitive disorders | Poster exhibition | Neurologic disorders (e.g. CNS malignancies) |
| PESUA25 | Unvaccinated individuals admitted to the ICU due to fatal COVID-19 showed progressive decay of unresponsive cytotoxic cells | Poster exhibition | Immune responses to SARS-Cov2 |
| PESUA24 | Chronic CNS inflammation in ART-suppressed SIV-infected rhesus macaques is associated with immune activation and viral persistence in the gut | Poster exhibition | Neuropathogenesis |
| PESUA23 | Longer intervals between SARS-CoV-2 infection and SpikeVax doses improve the neutralization of different variants of concern | Poster exhibition | Immune responses to SARS-Cov2 |